Skip to content
10-K

Annual Report

Zomedica Corp. ZOMDF

0001104659-26-028450

← back to feed
Filed
Mar 16, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 16, 2026 979.95M sh
Shares Diluted FY 2025 · Dec 31, 2025 979.95M sh
Shares Diluted FY 2025 · Dec 31, 2024 979.95M sh
Capex FY 2025 · Dec 31, 2025 $567K
Capex FY 2025 · Dec 31, 2024 $5.21M
Operating Cash Flow FY 2025 · Dec 31, 2025 −$17.65M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$23.63M
Cash And Equivalents FY 2025 · Dec 31, 2025 $9.02M
Cash And Equivalents FY 2025 · Dec 31, 2024 $7.02M
Stockholders Equity FY 2025 · Dec 31, 2025 $115.4M
Stockholders Equity FY 2025 · Dec 31, 2024 $195.66M
Stockholders Equity FY 2025 · Dec 31, 2023 $240.02M
Current Liabilities FY 2025 · Dec 31, 2025 $9.45M
Current Liabilities FY 2025 · Dec 31, 2024 $9.33M
Total Liabilities FY 2025 · Dec 31, 2025 $11.64M
Total Liabilities FY 2025 · Dec 31, 2024 $11.7M
Current Assets FY 2025 · Dec 31, 2025 $64.04M
Current Assets FY 2025 · Dec 31, 2024 $81.77M
Total Assets FY 2025 · Dec 31, 2025 $127.04M
Total Assets FY 2025 · Dec 31, 2024 $207.36M
Eps Diluted FY 2025 · Dec 31, 2025 −$0.08
Eps Diluted FY 2025 · Dec 31, 2024 −$0.05
Eps Basic FY 2025 · Dec 31, 2025 −$0.08
Eps Basic FY 2025 · Dec 31, 2024 −$0.05
Rd Expense FY 2025 · Dec 31, 2025 $7.17M
Rd Expense FY 2025 · Dec 31, 2024 $7.27M
Net Income FY 2025 · Dec 31, 2025 −$81.86M
Net Income FY 2025 · Dec 31, 2024 −$46.98M
Operating Income FY 2025 · Dec 31, 2025 −$84.35M
Operating Income FY 2025 · Dec 31, 2024 −$51.05M
Gross Profit FY 2025 · Dec 31, 2025 $21.68M
Gross Profit FY 2025 · Dec 31, 2024 $19.09M
Cost Of Revenue FY 2025 · Dec 31, 2025 $10.35M
Cost Of Revenue FY 2025 · Dec 31, 2024 $8.2M
Revenue FY 2025 · Dec 31, 2025 $32.03M
Revenue FY 2025 · Dec 31, 2024 $27.29M